Fremanezumab versus conventional preventive treatments as ≥2nd line prophylaxis of migraine – propensity score matched multiple cohort comparative retrospective longitudinal analyses of depersonalized 6-months real-world data of the German Pain e-Registry. (Freedom)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  German Pain e-Registry (GPeR)
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No